Nucana Plc current report, Q3 FY2025

Nucana Plc Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Nucana Plc, a foreign private issuer headquartered in Edinburgh, United Kingdom, for the month of September 2025. The filing reports an "Other Event" regarding a scheduled corporate presentation.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate event and does not contain financial statements or performance data.

Material Changes

No material financial changes versus a prior comparable period are reported in this document.

Outlook, Commentary, and Events

  • Upcoming Presentation: On September 3, 2025, the Company announced it will present at the European Society for Medical Oncology (ESMO) Congress 2025.
  • Event Details: The congress is scheduled for October 17-21, 2025, in Berlin, Germany.
  • Legal Status: The press release attached as Exhibit 99.1 is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section.

Key Investor Verification Points

  • Verify the content of the presentation to be delivered at the ESMO Congress 2025.
  • Confirm the date and location of the ESMO Congress (October 17-21, 2025, Berlin).
  • Note that the attached press release is not incorporated by reference into other filings unless expressly stated.